Next Article in Journal
Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment
Next Article in Special Issue
12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial
Previous Article in Journal
Riboflavin as a Mucosal Adjuvant for Nasal Influenza Vaccine
Previous Article in Special Issue
Avian Cell Line DuckCelt®-T17 Is an Efficient Production System for Live-Attenuated Human Metapneumovirus Vaccine Candidate Metavac®
 
 
Article

Article Versions Notes

Vaccines 2021, 9(11), 1297; https://doi.org/10.3390/vaccines9111297
Action Date Notes Link
article xml file uploaded 9 November 2021 07:50 CET Original file -
article xml uploaded. 9 November 2021 07:50 CET Update https://www.mdpi.com/2076-393X/9/11/1297/xml
article pdf uploaded. 9 November 2021 07:50 CET Version of Record https://www.mdpi.com/2076-393X/9/11/1297/pdf
article html file updated 9 November 2021 07:51 CET Original file -
article html file updated 30 July 2022 15:35 CEST Update https://www.mdpi.com/2076-393X/9/11/1297/html
Back to TopTop